We are preparing the requested document. Please wait, this may take a while...!
|Antigen||Wingless-Type MMTV Integration Site Family, Member 9A (WNT9A) Antibodies|
|Epitope||AA 348-363, C-Term Alternatives|
|Reactivity||Human, Mouse (Murine), Rat (Rattus) Alternatives|
|Conjugate||This WNT9A antibody is un-conjugated Alternatives|
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
|Supplier||Log in to see|
Product Details anti-WNT9A AntibodyTarget Details WNT9A Application Details Handling Images
|Purpose||Rabbit IgG polyclonal antibody for Protein Wnt-9a(WNT9A) detection. Tested with WB, IHC-P in Human,Mouse,Rat.|
Rabbit IgG polyclonal antibody for Protein Wnt-9a(WNT9A) detection. Tested with WB, IHC-P in Human,Mouse,Rat.
Gene Name: wingless-type MMTV integration site family, member 9A
Protein Name: Protein Wnt-9a
|Purification||Immunogen affinity purified.|
|Immunogen||A synthetic peptide corresponding to a sequence at the C-terminal of human WNT9A(348-363aa, YVECRQCTQREEVYTC), different from the mouse sequence by one amino acid.|
Target Details WNT9AProduct Details anti-WNT9A Antibody Application Details Handling Images back to top
|Alternative Name||WNT9A (WNT9A Antibody Abstract)|
Wingless-type MMTV integration site family, member 9A, also known as WNT9A or WNT14, is a human gene. The WNT gene family consists of structurally related genes that encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene is a member of the WNT gene family. It is expressed in gastric cancer cell lines. The protein encoded by this gene shows 75 % amino acid identity to chicken Wnt14, which has been shown to play a central role in initiating synovial joint formation in the chick limb. This gene contains 4 exons and spans about 27 kb of genomic DNA, in the chromosome 1q42 region.
Synonyms: WNT14|wingless-type MMTV integration site family, member 14|
Application DetailsProduct Details anti-WNT9A Antibody Target Details WNT9A Handling Images back to top
WB: Concentration: 0.1-0.5 μg/mL, Tested Species: Human, Rat, Predicted Species: Mouse
IHC-P: Concentration: 0.5-1 μg/mL, Tested Species: Human, Rat, Predicted Species: Mouse
|Restrictions||For Research Use only|
HandlingProduct Details anti-WNT9A Antibody Target Details WNT9A Application Details Images back to top
|Reconstitution||Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.|
|Buffer||Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.|
|Preservative||Sodium azide, Thimerosal (Merthiolate)|
|Precaution of Use||This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.|
|Handling Advice||Avoid repeated freezing and thawing.|
|Storage||4 °C/-20 °C|
At -20°C for one year. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20 °C for a longer time. Avoid repeated freezing and thawing.